Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

15
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
15

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single Percussive Ventilation Breath-hold Imaging and Delivery in Lung Tumor Stereotactic Ablative Radiation Therapy: Initial Observations From a Prospective Clinical Trial.

International journal of radiation oncology, biology, physics·2026
Same author

Synthetic CT imaging for pelvic and abdominal MR-only radiotherapy: Clinical validation on a 1.5T MR-Linac.

Journal of applied clinical medical physics·2026
Same author

Robust automatic soft tissue flap segmentation using a challenging case-enriched nnU-Net in head and neck CT images.

Scientific reports·2026
Same author

[Analysis of treatment practices for locally advanced head and neck squamous cell carcinoma: A survey from GORTEC].

Bulletin du cancer·2026
Same author

Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trial.

The lancet. Healthy longevity·2026
Same author

Postoperative SBRT and Severe Late Toxic Effects in Early-Stage Oropharyngeal and Oral Cavity Cancers: The STEREOPOSTOP-GORTEC 2017-03 Nonrandomized Clinical Trial.

JAMA network open·2026

Related Experiment Video

Updated: Oct 11, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.9K

Validation of Monte Carlo dose calculation algorithm for CyberKnife multileaf collimator.

Maude Gondré1, Fanny Marsolat1, Jean Bourhis2

  • 1Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.

Journal of Applied Clinical Medical Physics
|December 1, 2021
PubMed
Summary

The Monte Carlo (MC) algorithm for CyberKnife with a multileaf collimator (MLC) is clinically acceptable but underestimates dose by 1.5%. Use this algorithm cautiously in heterogeneous areas and for shallow tumors.

Keywords:
CyberKnifeMonte Carlo dose algorithmcommissioningmultileaf collimator

More Related Videos

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K

Related Experiment Videos

Last Updated: Oct 11, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.9K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Computational Dosimetry

Background:

  • Accurate dose calculation is crucial for effective radiation therapy.
  • The CyberKnife system with a multileaf collimator (MLC) requires precise dose verification.
  • Monte Carlo (MC) methods offer high accuracy in dose calculation.

Purpose of the Study:

  • To commission and validate the MC dose calculation algorithm for the CyberKnife MLC.
  • To assess the accuracy of the MC algorithm against measured dose distributions.
  • To determine the clinical applicability of the MC algorithm for treatment planning.

Main Methods:

  • Developed an MC model for the CyberKnife MLC within the treatment planning software (TPS).
  • Optimized MC parameters (maximum energy, source FWHM) by comparing calculated and measured tissue phantom ratios and profiles.
  • Validated the commissioned MC algorithm using ionization chambers, Gafchromic films, and patient-specific quality assurance (QA) with gamma index analysis.

Main Results:

  • Optimized MC parameters achieved good agreement with measurements (output factors within ±1%).
  • The MC model systematically underestimated dose by an average of -1.5%.
  • Dose underestimation increased with depth, reaching -3.0% at 15.5 cm.

Conclusions:

  • The commissioned MC algorithm for CyberKnife MLC is clinically acceptable.
  • A consistent dose underestimation of -1.5% necessitates careful application.
  • Recommended use in heterogeneous regions and for shallow-seated tumors to mitigate underestimation effects.